« Previous
Next »
European Journal of Surgical Oncology
Volume 34, Issue 2
, Pages 149-153
, February 2008
A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer
References
- Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792
- Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330(7485):220
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717
- Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ. 2000;321(7262):665–669
- . Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877
- . The mammography dilemma: a crisis for evidence-based medicine?. Ann Intern Med. 2002;137(5 Part 1):363–365
- . Spontaneous regression of cancerous tumors detected by mammography screening. JAMA. 2004;292(21):2579–2580
- . Breast cancer screening. IARC handbooks of cancer prevention. Lyon, France: IARC Press; 2002;
- . Some current issues in breast cancer screening. J Med Screen. 2005;12:128–133
- . Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328(7445):921–924
- . Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340–1342
- Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004;292(9):1064–1073
- Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–1886
- Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987;56(4):489–492
- Hormone replacement therapy in relation to breast cancer. JAMA. 2002;287(6):734–741
- The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Ann Surg Oncol. 2004;11(1):52–58
- Type and duration of exogenous hormone use affects breast cancer histology. Ann Surg Oncol. 2007 Feb;14(2):695–703
- . “Benign” tumors and “early detection” in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000;160(8):1109–1115
- Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999;91(23):2020–2028
- . Advances in axillary surgery for breast cancer-time for a tailored approach. Eur J Surg Oncol. 2005;31(9):929–931
- Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer. J Med Screen. 2004;11(3):130–134
- Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer. 2005;92(1):156–161
- . Over-diagnosis in breast cancer screening. BMJ. 2006;332(7543):691–692
- Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56(6):814–819
- . Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol. 1991;44(1):29–39
- . Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?. Ann Intern Med. 1997;127(11):1023–1028
PII: S0748-7983(07)00152-7
doi: 10.1016/j.ejso.2007.03.025
© 2007 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Surgical Oncology
Volume 34, Issue 2
, Pages 149-153
, February 2008
